Bioatla Inc

Company Profile

Bioatla Inc had its IPO on 2020-12-16 under the ticker symbol BCAB.

The company operates in the Healthcare sector and Biotechnology industry. Bioatla Inc has a staff strength of 66 employees.

Stock update

Shares of Bioatla Inc opened at $2.37 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $2.2 - $2.43, and closed at $2.21.

This is a -6.36% slip from the previous day's closing price.

A total volume of 284,135 shares were traded at the close of the day’s session.

In the last one week, shares of Bioatla Inc have slipped by -15.65%.

Bioatla Inc's Key Ratios

Bioatla Inc has a market cap of $182.81 million, indicating a price to book ratio of 2.5839 and a price to sales ratio of 989.2236.

In the last 12-months Bioatla Inc’s revenue was $0 with a gross profit of $-79347000 and an EBITDA of $-111545000. The EBITDA ratio measures Bioatla Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bioatla Inc’s operating margin was 0% while its return on assets stood at -32.38% with a return of equity of -63.32%.

In Q1, Bioatla Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 31.6%.

Bioatla Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-3.03 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bioatla Inc’s profitability.

Bioatla Inc stock is trading at a EV to sales ratio of 134.3737 and a EV to EBITDA ratio of -1.9263. Its price to sales ratio in the trailing 12-months stood at 989.2236.

Bioatla Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$204.55 million

Total Liabilities

$26.26 million

Operating Cash Flow

$-50000.00

Capital Expenditure

$50000

Dividend Payout Ratio

0%

Bioatla Inc ended 2024 with $204.55 million in total assets and $0 in total liabilities. Its intangible assets were valued at $204.55 million while shareholder equity stood at $156.43 million.

Bioatla Inc ended 2024 with $0 in deferred long-term liabilities, $26.26 million in other current liabilities, 5000.00 in common stock, $-320261000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $192.69 million and cash and short-term investments were $192.69 million. The company’s total short-term debt was $1,545,000 while long-term debt stood at $0.

Bioatla Inc’s total current assets stands at $199.72 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $8.05 million and inventory worth $0.

In 2024, Bioatla Inc's operating cash flow was $-50000.00 while its capital expenditure stood at $50000.

Comparatively, Bioatla Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$2.21

52-Week High

$12.15

52-Week Low

$2.235

Analyst Target Price

$15

Bioatla Inc stock is currently trading at $2.21 per share. It touched a 52-week high of $12.15 and a 52-week low of $12.15. Analysts tracking the stock have a 12-month average target price of $15.

Its 50-day moving average was $2.72 and 200-day moving average was $4.07 The short ratio stood at 8.61 indicating a short percent outstanding of 0%.

Around 1407.6% of the company’s stock are held by insiders while 7137.5% are held by institutions.